Know Labs, Inc. (OTCQB: KNWN) formerly known as Visualant, is a premier non-invasive medical diagnostics company that is leveraging its proprietary electromagnetic energy technology platforms, namely ChromaID and Bio-RFID technologies, to capture the unique molecular signature of any substance or material. The Company shared preliminary study...
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company, is developing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, an approach that has the potential to address the unmet needs in cardiovascular, metabolic and fatty liver diseases. The Company’s research is...
Aeva Technologies, Inc. (NYSE: AEVA) a developer of cutting-edge optical-based sensors for autonomous vehicles, debuted on the US stock market on March 15, 2021, through its merger with SPAC InterPrivate Acquisition Corp. The Company raised close to $560 million in gross proceeds from the deal,...
Replimune group, Inc. (NASDAQ: REPL) is leveraging the power of its proprietary Immulytic platform to create a leading-edge oncolytic immunotherapy program that can generate a patient-specific local as well as systemic immune response. The therapies not only fight against the current cancer but also eliminate...
The International Energy Agency predicts that Electric Vehicles, which stand at 3 million today, will grow to 125 million by 2030. The Global Electric Vehicle market is all set to compete with the internal combustion engine (ICE) vehicles in the next five-year, accounting for one...
Ayro, Inc. (NASDAQ: AYRO), a designer and manufacturer of emissions-free electric vehicles for last-mile delivery and community transport, announced an agreement with one of the world’s largest pure-play automotive fleet managers namely Element Fleet Management (ELEEF). Element currently runs operations in 5 countries and manages...
Infinity Pharmaceuticals (NASDAQ: INFI) novel approach is based on Targeting Immune Suppressive Macrophages by selectively inhibiting PI3K-Gamma. The Company’s lead candidate eganelisib, is a first-in-class, oral, once-daily selective inhibitor of phosphoinositide-3-kinase gamma (PI3K-gamma), that has the potential to transform the immuno-oncology space. IPI-549 has demonstrated...
Immersion Corporation, (NASDAQ: IMMR) develops touch and motion control technologies for the digital world. The Company has over 15 award-winning designs and products and serves more than 150 licensed customers and 3 billion devices that are using its technology. The technology developed by the Company...
There is a lot of buzz around Acer Therapeutics (NASDAQ: ACER) resulting in the stock zooming skywards. The sudden interest in the company is based on rumors that the Company is likely to be acquired by Relief Therapeutics (OTCQB: RLFTF), a biopharmaceutical company whose lead...
While Industries across the globe are grappling with the pandemic and its impact on their operations, the Technology Industry has been focused on minimizing the impact and marching ahead with its innovations and breakthroughs, be it electric charging, semiconductor solutions or critical communication systems. We take...
